0001478304-24-000001.txt : 20240808 0001478304-24-000001.hdr.sgml : 20240808 20240808123955 ACCESSION NUMBER: 0001478304-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 EFFECTIVENESS DATE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Noveome Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001478304 ORGANIZATION NAME: IRS NUMBER: 510404343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-490042 FILM NUMBER: 241187158 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY DRIVE STREET 2: SUITE 200 CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: 412-402-9999 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY DRIVE STREET 2: SUITE 200 CITY: PITTSBURGH STATE: PA ZIP: 15219 FORMER COMPANY: FORMER CONFORMED NAME: Noveome Biotherapeutics, Inc.. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Noveome Biotherapeutics, Inc. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Stemnion, Inc. DATE OF NAME CHANGE: 20091208 D/A 1 primary_doc.xml X0708 D/A LIVE 0001478304 Noveome Biotherapeutics, Inc. 100 TECHNOLOGY DRIVE SUITE 200 PITTSBURGH PA PENNSYLVANIA 15219 412-402-9999 DELAWARE Noveome Biotherapeutics, Inc.. Noveome Biotherapeutics, Inc. Stemnion, Inc. Corporation true Gretchen Kraemer 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Executive Officer Robert Langer 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Ronald Poropatich 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Eric Keller 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Houman Hemmati 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Craig Nemiroff 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Michael Kaufman 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Patrick Welch 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Executive Officer Biotechnology Decline to Disclose 06b true 0001478304-23-000001 2023-08-02 true true false 0 51270077 36184531 15085546 Total amount sold includes promissory note conversion amounts. false 66 0 0 186000 Accrued backpay false Noveome Biotherapeutics, Inc. Patrick Welch Patrick Welch CEO & Director 2024-08-08